Viewing Study NCT05078593

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:25 AM
Ignite Modification Date: 2026-01-20 @ 10:26 AM
Study NCT ID: NCT05078593
Status: COMPLETED
Last Update Posted: 2024-02-23
First Post: 2021-10-13
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of HLX26 Monoclonal Antibody Injection in Patients With Solid Tumor or Lymphoma
Sponsor: Shanghai Henlius Biotech
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Solid Tumor, Adult View
None Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None LAG-3 View